Published in Cardiovasc Diabetol on May 21, 2015
Use of imaging and clinical data to screen for cardiovascular disease in asymptomatic diabetics. Cardiovasc Diabetol (2016) 0.79
Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry. Cardiovasc Diabetol (2017) 0.75
Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study. Cardiovasc Diabetol (2017) 0.75
Impact of Body Mass Index on Vascular Calcification and Pericardial Fat Volume Among Patients with Suspected Coronary Artery Disease. Sultan Qaboos Univ Med J (2016) 0.75
Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011). Cardiovasc Diabetol (2017) 0.75
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol (1990) 28.97
Inflammation in atherosclerosis. Nature (2002) 28.92
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol (2010) 9.44
Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 8.72
Coronary plaque disruption. Circulation (1995) 8.04
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol (2001) 2.57
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J (1983) 2.55
Normal-weight obese syndrome: early inflammation? Am J Clin Nutr (2007) 2.10
Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf) (2013) 1.88
Rationale for redefining obesity in Asians. Ann Acad Med Singapore (2009) 1.86
Association between brachial-ankle pulse wave velocity and cardiovascular risk factors in healthy adolescents. J Pediatr (2007) 1.74
The pathophysiology of acute coronary syndromes. Heart (2000) 1.67
Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation. Circ Cardiovasc Imaging (2012) 1.66
A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care (2005) 1.66
Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens (2003) 1.60
Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology (2010) 1.45
Ageing and vascular ageing. Postgrad Med J (2006) 1.36
2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul) (2014) 1.27
Intracoronary ultrasound imaging: correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol (1993) 1.23
Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention. Eur Heart J (1995) 1.18
Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis (2006) 1.17
Natural history of asymptomatic carotid plaque. Five year follow-up study. Am J Surg (1987) 0.99
Assessing abdominal fatness with local bioimpedance analysis: basics and experimental findings. Int J Obes Relat Metab Disord (2001) 0.94
Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis. Atherosclerosis (2014) 0.92
Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis (2009) 0.92
Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol (2008) 0.90
Clinical usefulness and limitations of brachial-ankle pulse wave velocity in the evaluation of cardiovascular complications in hypertensive patients. Hypertens Res (2006) 0.88
Coronary heart disease deaths and infarctions in people with little or no coronary calcium. Lancet (1999) 0.88
Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health. Cardiovasc Diabetol (2014) 0.86
Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. Cardiovasc Diabetol (2014) 0.85
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese. Cardiovasc Diabetol (2014) 0.84
Vascular inflammation in metabolically abnormal but normal-weight and metabolically healthy obese individuals analyzed with ¹⁸F-fluorodeoxyglucose positron emission tomography. Am J Cardiol (2014) 0.78
Arterial stiffness is inversely associated with a better running record in a full course marathon race. J Exerc Nutrition Biochem (2014) 0.77